- Question from girliebiker: Any news on length of time to take Herceptin?
- Answers - Eric Winer, M.D. For any woman who has anything other than metastatic breast cancer, to prevent a recurrence, Herceptin (chemical name: trastuzumab) is often used in conjunction with chemotherapy and the standard time is 1 year. We don't know if less than 1 year is as good as a year, and we don't know if more than a year is better than 1 year. One study looked at 2 years versus 1 year and we have no information on that study yet. So the right amount of time is 1 year.
The Ask-the-Expert Online Conference called Updates From the 2010 San Antonio Breast Cancer Symposium featured Eric Winer, M.D. and Marisa Weiss, M.D. answering your questions about the latest updates on breast cancer risk, screening, and treatment in early and metastatic breast cancer.
Editor's Note: This conference took place in December 2010.
The materials presented in these conferences do not necessarily reflect the views of Breastcancer.org. A qualified healthcare professional should be consulted before using any therapeutic product or regimen discussed. All readers should verify all information and data before employing any therapies described here.
A production of LiveWorld, Inc.
Copyright 2010. All rights reserved.